TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32285617

Group type: EXPERIMENTAL
Intervention: PRP injection
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: PRP application
Number of subjects: 90

Group type: COMPARATOR
Intervention: Compression therapy
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 90
Study: 34911681

Group type: EXPERIMENTAL
Intervention: Nivolumab 240 mg intravenously on days 1 and 15 + Tadalafil 10 mg orally once daily for 4 weeks
Number of subjects: 46

Group type: COMPARATOR
Intervention: Nivolumab 240 mg intravenously on days 1 and 15
Number of subjects: 46
Study: 34871484

Group type: EXPERIMENTAL
Intervention: Intervention group (n=50)
Number of subjects: 150
Study: 32985439

Group type: EXPERIMENTAL
Intervention: Innovative Mobile-phone Technology for Community Health Operations (ImTeCHO)
Number of subjects: 45
Study: 34798846

Group type: EXPERIMENTAL
Intervention: Sonidegib 200 mg once daily
Number of subjects: 66
Study: 33347567

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation of 10 μg daily from age 2 weeks to 2 years
Number of subjects: 812

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation of 30 μg daily from age 2 weeks to 2 years
Number of subjects: 812

Group type: EXPERIMENTAL
Intervention: Comparison of group 30 (30 μg) vs group 10 (10 μg)
Number of subjects: 812

Group type: EXPERIMENTAL
Intervention: Highest quartile of 25(OH)D (> 121 nmol/L)
Number of subjects: 812
Study: 35239136

Group type: EXPERIMENTAL
Intervention: Synbiotic food consumption
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 52
Study: 32182633

Group type: EXPERIMENTAL
Intervention: RP-HPLC-MS/MS and RP-HPLC-DAD-MS methods for analysis of ecdysteroids
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: HPLC-MS/MS with a short analysis time
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: HPLC-MS/MS with a longer analysis time
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: HPLC-DAD-MS
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Characterisation of ecdysteroids from specific species
Number of subjects: 160
Study: 35322373

Group type: EXPERIMENTAL
Intervention: G-CSF plus standard medical therapy
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo plus standard medical therapy
Number of subjects: 70
Study: 33093216

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 201

Group type: COMPARATOR
Intervention: Placebo/nil
Number of subjects: 201
Study: 34103393

Group type: EXPERIMENTAL
Intervention: Intravenous thrombolysis (IVT) alone
Number of subjects: 247
Study: 32474650

Group type: EXPERIMENTAL
Intervention: Teriparatide (20 μg subcutaneous daily)
Number of subjects: 1360

Group type: COMPARATOR
Intervention: Risedronate (35 mg oral weekly)
Number of subjects: 1360

Group type: EXPERIMENTAL
Intervention: Teriparatide
Number of subjects: 1360

Group type: COMPARATOR
Intervention: Teriparatide and Risedronate
Number of subjects: 1360
Study: 33739197

Group type: EXPERIMENTAL
Intervention: Remote ischemic conditioning
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (medical therapy alone)
Number of subjects: 40
Study: 33091344

Group type: EXPERIMENTAL
Intervention: Flexible assertive community treatment (FACT)
Number of subjects: 2034

Group type: COMPARATOR
Intervention: Control groups (CMHTs and ACT teams)
Number of subjects: 2034
Study: 35732397

Group type: EXPERIMENTAL
Intervention: mHealth application for treatment support
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 0
Study: 32623928

Group type: EXPERIMENTAL
Intervention: Bleomycin‐containing combination chemotherapy regimen
Number of subjects: 506

Group type: EXPERIMENTAL
Intervention: Anti‐Pneumocystis prophylaxis
Number of subjects: 506

Group type: COMPARATOR
Intervention: Cumulative incidence of PCP
Number of subjects: 506

Group type: COMPARATOR
Intervention: Mortality 30 days from PCP diagnosis
Number of subjects: 506
Study: 36306029

Group type: EXPERIMENTAL
Intervention: Skin cancer prevention education
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Education + UV photo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Education + genetic testing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Education + UV photo + genetic testing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 32817271

Group type: EXPERIMENTAL
Intervention: Cardiovascular magnetic resonance (CMR)
Number of subjects: 1202

Group type: EXPERIMENTAL
Intervention: Myocardial perfusion scintigraphy (MPS)
Number of subjects: 1202

Group type: COMPARATOR
Intervention: NICE guideline‐guided care
Number of subjects: 1202
Study: 32939539

Group type: EXPERIMENTAL
Intervention: NMES combined with ECC
Number of subjects: 112

Group type: COMPARATOR
Intervention: NMES placebo combined with ECC placebo
Number of subjects: 112
Study: 35705423

Group type: EXPERIMENTAL
Intervention: Higher calorie refeeding
Number of subjects: 120

Group type: COMPARATOR
Intervention: Lower calorie refeeding
Number of subjects: 120
Study: 33188552

Group type: EXPERIMENTAL
Intervention: Bergamot phytosome (500 mg, two daily tablets)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo (two daily tablets)
Number of subjects: 64
Study: 32559463

Group type: EXPERIMENTAL
Intervention: X‐pander®
Number of subjects: 54

Group type: COMPARATOR
Intervention: Trial cups
Number of subjects: 54
Study: 33580248

Group type: COMPARATOR
Intervention: SLE (−) population
Number of subjects: 1747
Study: 32340817

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery (LAP)
Number of subjects: 3051

Group type: COMPARATOR
Intervention: Open surgery (OP)
Number of subjects: 3051
Study: 36195936

Group type: EXPERIMENTAL
Intervention: Heavy-slow resistance training, patient education, and a heel insert
Number of subjects: 70

Group type: COMPARATOR
Intervention: Radiofrequency microtenotomy treatment, patient education, and a heel insert
Number of subjects: 70
Study: 33940563

Group type: EXPERIMENTAL
Intervention: Agomelatine in combination with conventional cerebrovascular disease medication
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Sertraline in combination with conventional cerebrovascular disease medication
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Escitalopram in combination with conventional cerebrovascular disease medication
Number of subjects: 165

Group type: COMPARATOR
Intervention: Conventional treatment alone (Control group)
Number of subjects: 165
Study: 36235553

Group type: EXPERIMENTAL
Intervention: Protein-reduced intervention infant formula (IF)
Number of subjects: 161

Group type: COMPARATOR
Intervention: Control infant formula (CF)
Number of subjects: 161

Group type: COMPARATOR
Intervention: Breastfed group (BF)
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: IGF-1 serum concentrations at 4 months
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Insulin levels at 4 months
Number of subjects: 161
Study: 34014689

Group type: EXPERIMENTAL
Intervention: Individualized Assessment and Treatment Program (IATP)
Number of subjects: 198

Group type: COMPARATOR
Intervention: Conventional motivational enhancement + cognitive-behavioral treatment (MET-CBT)
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: IATP
Number of subjects: 198

Group type: COMPARATOR
Intervention: MET-CBT
Number of subjects: 198
Study: 32341121

Group type: EXPERIMENTAL
Intervention: Tolcapone (COMT inhibitor)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 35501981

Group type: EXPERIMENTAL
Intervention: Gamified app
Number of subjects: 289

Group type: COMPARATOR
Intervention: Nongamified app
Number of subjects: 289
Study: 32862453

Group type: EXPERIMENTAL
Intervention: Micronutrient powder containing 12 mg iron for 12 weeks
Number of subjects: 22
Study: 36115795

Group type: EXPERIMENTAL
Intervention: Home-based telerehabilitation (HBT)
Number of subjects: 45

Group type: COMPARATOR
Intervention: In-person (IP) programs
Number of subjects: 45
Study: 32681717

Group type: EXPERIMENTAL
Intervention: Complete FFR-guided revascularization
Number of subjects: 110

Group type: COMPARATOR
Intervention: Culprit-only revascularization
Number of subjects: 110
Study: 32605396

Group type: EXPERIMENTAL
Intervention: Self-reported physical activity
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Total physical activity
Number of subjects: 150
Study: 32475261

Group type: EXPERIMENTAL
Intervention: ProCog‐SEP (cognitive rehabilitation program)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Placebo program (non-cognitive exercises)
Number of subjects: 128
Study: 33581820

Group type: EXPERIMENTAL
Intervention: tE2 patches (four 100 μg patches per 24 h, changed twice weekly)
Number of subjects: 1694

Group type: COMPARATOR
Intervention: LHRHa
Number of subjects: 1694

Group type: EXPERIMENTAL
Intervention: tE2 patches
Number of subjects: 1694
Study: 33345879

Group type: EXPERIMENTAL
Intervention: Standardized induction protocol (n=491)
Number of subjects: 855

Group type: COMPARATOR
Intervention: Observational arm (n=364)
Number of subjects: 855
Study: 35129210

Group type: EXPERIMENTAL
Intervention: Informed respondents regarding aducanumab's potential clinical and economic impact
Number of subjects: 1025

Group type: EXPERIMENTAL
Intervention: Support for restricting aducanumab access
Number of subjects: 1025

Group type: EXPERIMENTAL
Intervention: Willingness to enroll family members in trials
Number of subjects: 1025

Group type: EXPERIMENTAL
Intervention: Opinion on market withdrawal of aducanumab
Number of subjects: 1025

Group type: EXPERIMENTAL
Intervention: Willingness to pay higher premiums for coverage
Number of subjects: 1025
Study: 33928797

Group type: EXPERIMENTAL
Intervention: GP40071 insulin aspart (GP‐Asp)
Number of subjects: 264

Group type: COMPARATOR
Intervention: NovoRapid® (NN‐Asp)
Number of subjects: 264
Study: 32697288

Group type: EXPERIMENTAL
Intervention: Dialectical Behavior Therapy for PTSD (DBT-PTSD)
Number of subjects: 193

Group type: COMPARATOR
Intervention: Cognitive Processing Therapy (CPT)
Number of subjects: 193
Study: 35413921

Group type: EXPERIMENTAL
Intervention: Standard of care plus icatibant (30 mg subcutaneously 3 times a day for 3 days)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standard of care alone
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Standard of care plus icatibant
Number of subjects: 120
Study: 34156451

Group type: EXPERIMENTAL
Intervention: 20-minute seated lunch condition
Number of subjects: 38

Group type: COMPARATOR
Intervention: 10-minute seated lunch condition
Number of subjects: 38
Study: 32638445

Group type: EXPERIMENTAL
Intervention: Cinnamon powder (three capsules/day each containing 600 mg of cinnamon)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo (three capsules/day each containing 100 mg of corn starch)
Number of subjects: 50
Study: 33871219

Group type: EXPERIMENTAL
Intervention: Early lumbar disc herniation surgery within the first 6 months
Number of subjects: 67

Group type: COMPARATOR
Intervention: Delayed lumbar disc herniation surgery after 6 months
Number of subjects: 67
Study: 35807912

Group type: EXPERIMENTAL
Intervention: Early introduction of solid foods (10‐12th week corrected age)
Number of subjects: 177

Group type: COMPARATOR
Intervention: Late introduction of solid foods (16‐18th week corrected age)
Number of subjects: 177
Study: 32654610

Group type: EXPERIMENTAL
Intervention: Ipsilateral familiarization
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Contralateral familiarization
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Left foot tested
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Right foot tested
Number of subjects: 60
Study: 35080502

Group type: EXPERIMENTAL
Intervention: Telemonitoring system with decision support
Number of subjects: 96

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 96
Study: 32979516

Group type: EXPERIMENTAL
Intervention: SOS-GR
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 3D-DLCS
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: TV-CS
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: TV-BL-CS
Number of subjects: 8

Group type: COMPARATOR
Intervention: NUFFT
Number of subjects: 8
Study: 35993422

Group type: EXPERIMENTAL
Intervention: Enhanced HR Only
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Enhanced SpO2 Only
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Enhanced Both
Number of subjects: 41

Group type: COMPARATOR
Intervention: No Enhancement
Number of subjects: 41
Study: 33906807

Group type: EXPERIMENTAL
Intervention: 10 mL PRP intracavernosal injections, n = 30
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo intracavernosal injections, n = 30
Number of subjects: 60
Study: 32601289

Group type: EXPERIMENTAL
Intervention: Mustard aphid (L. erysimi)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Cowpea aphid (A. craccivora)
Number of subjects: 2
Study: 32762792

Group type: EXPERIMENTAL
Intervention: Art Therapy (AT)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control
Number of subjects: 49
Study: 33021404

Group type: EXPERIMENTAL
Intervention: Deep learning model using preablation pulmonary vein computed tomography images for predicting NPV triggers
Number of subjects: 521
Study: 34156769

Group type: EXPERIMENTAL
Intervention: mTBI
Number of subjects: 9428

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 9428
Study: 33448617

Group type: EXPERIMENTAL
Intervention: Cognitive Analytic Therapy (CAT)
Number of subjects: 79
Study: 34333502

Group type: EXPERIMENTAL
Intervention: 4% chlorhexidine
Number of subjects: 85

Group type: COMPARATOR
Intervention: 10% iodine
Number of subjects: 85
Study: 33894153

Group type: EXPERIMENTAL
Intervention: Single dose of 600,000 IU of vitamin D3
Number of subjects: 630

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 630
Study: 32883721

Group type: EXPERIMENTAL
Intervention: Internet-based intervention based on Acceptance and Commitment Therapy (ACT), 7 modules over 7 weeks, guided by a trained e-coach.
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: Internet-based intervention based on Acceptance and Commitment Therapy (ACT)
Number of subjects: 286

Group type: COMPARATOR
Intervention: Enhanced treatment as usual (TAU+)
Number of subjects: 286
Study: 36149205

Group type: EXPERIMENTAL
Intervention: pQLB
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: pTAPB
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control
Number of subjects: 90
Study: 33263286

Group type: EXPERIMENTAL
Intervention: Movement Matters Activity Program (MMAP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MMAP implementation strategies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MMAP training and resources
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MMAP implementation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Successful MMAP implementation
Number of subjects: 0
Study: 34257088

Group type: EXPERIMENTAL
Intervention: Structured pharmacotherapy optimisation intervention
Number of subjects: 2008

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 2008
Study: 34197339

Group type: EXPERIMENTAL
Intervention: Homeopathic treatment (Berberis 6CH, Mercurius Solubilis/Belladona/Hepar Sulfur, Pyrogenium 200CH biotherapic) prescribed in diluted low ultra-diluted concentration doses for all signs and symptoms, with biotherapics used for chronic stimulation.
Number of subjects: 85

Group type: COMPARATOR
Intervention: Control group (Conventional periodontal therapy without homeopathy)
Number of subjects: 85
Study: 33025229

Group type: EXPERIMENTAL
Intervention: Below-knee compression garment (CG) during exercise (100 maximal isokinetic eccentric contractions)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (CONCG: CG, no exercise)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Exercise without CG (EXP)
Number of subjects: 24
Study: 36279373

Group type: EXPERIMENTAL
Intervention: Supravenous laser blood irradiation, pulsed magnetotherapy, dry-air carbon dioxide baths, structured therapeutic exercises in the gym.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard elastic compression (compression class 2-3) and lymphovenotonics (diosmin and hesperidin) with therapeutic exercises in the gym.
Number of subjects: 60
Study: 33153828

Group type: EXPERIMENTAL
Intervention: Quetiapine (300 mg nightly)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 130

Group type: COMPARATOR
Intervention: Quetiapine and Placebo
Number of subjects: 130
Study: 35245446

Group type: EXPERIMENTAL
Intervention: Toripalimab plus paclitaxel plus cisplatin (TP)
Number of subjects: 514

Group type: COMPARATOR
Intervention: Placebo plus paclitaxel plus cisplatin (TP)
Number of subjects: 514
Study: 36062743

Group type: EXPERIMENTAL
Intervention: Netakimab (120 mg subcutaneous at weeks 0, 1, 2, and every other week thereafter)
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Netakimab
Number of subjects: 228

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 228
Study: 32140705

Group type: EXPERIMENTAL
Intervention: PCV13 (2015-2017)
Number of subjects: 30000

Group type: EXPERIMENTAL
Intervention: PCV7/PCV13 implementation
Number of subjects: 30000
Study: 34738962

Group type: EXPERIMENTAL
Intervention: Occupational Physical Activity (OPA)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Rest (REST)
Number of subjects: 11
Study: 34066659

Group type: EXPERIMENTAL
Intervention: Continuous education program with 10 themes during 2017–2018
Number of subjects: 85

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 85
Study: 33036921

Group type: EXPERIMENTAL
Intervention: Pentoxifylline 400 mg, three times daily, for 9 doses within 72 hours of diagnosis
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Pentoxifylline
Number of subjects: 83
Study: 32631713

Group type: EXPERIMENTAL
Intervention: WALANT
Number of subjects: 185
Study: 36229048

Group type: EXPERIMENTAL
Intervention: Otilimab 90 mg plus standard care
Number of subjects: 1156

Group type: COMPARATOR
Intervention: Placebo plus standard care
Number of subjects: 1156
Study: 32920677

Group type: EXPERIMENTAL
Intervention: Baseline EQ-5D score at 0 week
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Baseline VAS for low back pain at 0 week
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Fluid-intensity T2-weighted MR image patterns
Number of subjects: 166
Study: 32376815

Group type: EXPERIMENTAL
Intervention: Resistance exercise program using an elastic band for 8 weeks, 3 days a week
Number of subjects: 72

Group type: COMPARATOR
Intervention: Normal daily activities for 8 weeks
Number of subjects: 72
Study: 34563635

Group type: COMPARATOR
Intervention: Standard parotid-sparing radiation therapy
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Stem cell sparing (SCS) radiation therapy
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 102
Study: 33620899

Group type: EXPERIMENTAL
Intervention: Spanish-translated survey
Number of subjects: 30

Group type: COMPARATOR
Intervention: Cognitive interviews
Number of subjects: 30
Study: 34391941

Group type: EXPERIMENTAL
Intervention: Brain development claim
Number of subjects: 2190

Group type: EXPERIMENTAL
Intervention: Immunity-related claim
Number of subjects: 2190

Group type: COMPARATOR
Intervention: Control claim (new and improved)
Number of subjects: 2190
Study: 34196379

Group type: EXPERIMENTAL
Intervention: No-suction
Number of subjects: 323

Group type: EXPERIMENTAL
Intervention: 10 mL suction
Number of subjects: 323

Group type: COMPARATOR
Intervention: 20 mL suction
Number of subjects: 323
Study: 34898293

Group type: EXPERIMENTAL
Intervention: Menopausal hormone therapy (MHT) with exercise and education
Number of subjects: 132

Group type: COMPARATOR
Intervention: Placebo with exercise and education
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Tendon-specific exercise
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Sham exercise
Number of subjects: 132
Study: 33373538

Group type: EXPERIMENTAL
Intervention: Advance Care Planning (ACP) intervention
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: ACP decision aid
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Post-intervention ACP conversations
Number of subjects: 198
Study: 34330211

Group type: EXPERIMENTAL
Intervention: Lower limb resistance exercise for 12 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 60
Study: 33055176

Group type: EXPERIMENTAL
Intervention: Usual care plus $40 bonus programme
Number of subjects: 4172

Group type: EXPERIMENTAL
Intervention: Usual care plus no bonus programme
Number of subjects: 4172

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 4172

Group type: EXPERIMENTAL
Intervention: Usual care plus team based programmes
Number of subjects: 4172

Group type: EXPERIMENTAL
Intervention: Usual care plus individual based programmes
Number of subjects: 4172

Group type: EXPERIMENTAL
Intervention: Usual care plus $20 bonus programme
Number of subjects: 4172
Study: 33526383

Group type: EXPERIMENTAL
Intervention: e-GW
Number of subjects: 588

Group type: COMPARATOR
Intervention: GW-C
Number of subjects: 588
Study: 35608484

Group type: EXPERIMENTAL
Intervention: Liberal approach to glucose control (IV insulin commenced at blood glucose >252 mg/dl, titrated to 180-252 mg/dl)
Number of subjects: 419

Group type: COMPARATOR
Intervention: Control approach to glucose control (IV insulin commenced at blood glucose >180 mg/dl, titrated to 108-180 mg/dl)
Number of subjects: 419
Study: 34022750

Group type: EXPERIMENTAL
Intervention: Topical capsaicin (0.075%)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Non-sensitizing placebo (Lubriderm)
Number of subjects: 37
Study: 33288086

Group type: EXPERIMENTAL
Intervention: Tazarotene 0.05% gel with NB-UVB
Number of subjects: 30
Study: 36370871

Group type: EXPERIMENTAL
Intervention: Relugolix combination therapy (40 mg relugolix, 1 mg estradiol, and 0.5 mg norethindrone acetate once daily)
Number of subjects: 509

Group type: EXPERIMENTAL
Intervention: Relugolix combination therapy
Number of subjects: 509

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 509